細胞療法&組織工学の世界市場 2022年-2026年

【英語タイトル】Global Cell Therapy and Tissue Engineering Market Research Report 2022-2026

9Dimen Researchが出版した調査資料(DMN22OT2091)・商品コード:DMN22OT2091
・発行会社(調査会社):9Dimen Research
・発行日:2022年10月(※2025年版があります。お問い合わせください。)
・ページ数:143
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル、北アメリカ、ヨーロッパ、アジア太平洋
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,200 ⇒換算¥486,400見積依頼/購入/質問フォーム
Global/Corporate User(法人閲覧用)USD5,800 ⇒換算¥881,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

米中貿易戦争、世界経済の不安定性と不確実性は世界の細胞療法&組織工学市場に大きな影響を与えるでしょう。細胞療法&組織工学市場資料は、主要地域(北アメリカ、ヨーロッパ、アジア太平洋)と主要国(アメリカ、ドイツ、英国、日本、韓国、中国)に焦点を当てた、世界の主要地域の市場状況に関する専門的かつ包括的な調査資料です。この資料では、世界の細胞療法&組織工学市場規模は 2022年にXX百万ドルと評価され、2026年末までにXX百万ドルに達すると予測されており、2022年から2026年にかけてXX%のCAGRで成長すると予測されています。
本調査資料に記載されている主要な企業は、Betalin Therapeutics、BioCardia, Inc、BioReliance Corporation、Biosolution Co.、Brainstorm Cell Therapeutics, Inc、MaxCyte, Inc、Medigene AG、MEDIPOST CO.、Mesoblast Limited、Miromatrix Medical, Inc.、MolMed S.p.A、Mustang Bio, Inc、NantKwest, Inc.、Neuralstem, Inc、NexImmune, Inc.、Nohla Therapeutics, Inc、ReNeuron Group plc、Richter-Helm BioLogics GmbH & Co. KG、RoosterBio, Inc、RoslinCT、Rubius Therapeutics, Inc.、Sangamo Therapeutics, Inc、Voyager Therapeutics, Inc、Waisman Biomanufacturing、WindMIL Therapeutics, Inc.、Wuxi App Tec, Inc.、ReNeuron Group plc、Richter-Helm BioLogics GmbH & Co. KG、RoosterBio, Inc、RoslinCT、……などです。

本資料は、世界の細胞療法&組織工学市場(2022年-2026年)について調査・分析し、細胞療法&組織工学の世界市場規模、市場予測、市場動向、上流市場分析、下流市場分析、アジア市場動向、北アメリカ市場動向、ヨーロッパ市場動向、マーケティングチャネル分析、投資可能性分析、メーカー分析などの情報を掲載しています。また、種類別(細胞治療、組織工学、……など)、用途別(細胞欠陥、遺伝病、神経変性疾患、組織悪性腫瘍、……など)のセグメント情報も収録しています。

・細胞療法&組織工学の市場概要
・細胞療法&組織工学の上流・下流市場分析
・細胞療法&組織工学のアジア市場:市場分析(製品開発、競争環境、市場動向等)
・細胞療法&組織工学のアジア市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・細胞療法&組織工学のアジア市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・細胞療法&組織工学のアジア市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・細胞療法&組織工学の北アメリカ市場:市場分析(製品開発、競争環境、市場動向等)
・細胞療法&組織工学の北アメリカ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・細胞療法&組織工学の北アメリカ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・細胞療法&組織工学の北アメリカ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・細胞療法&組織工学のヨーロッパ市場:市場分析(製品開発、競争環境、市場動向等)
・細胞療法&組織工学のヨーロッパ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・細胞療法&組織工学のヨーロッパ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・細胞療法&組織工学のヨーロッパ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・細胞療法&組織工学のマーケティングチャネル分析
・マクロ経済分析(中国経済、ヨーロッパ経済、アメリカ経済、日本経済、グローバル経済)
・細胞療法&組織工学の投資可能性分析
・細胞療法&組織工学の世界市場規模(2017年-2022年推移、2022年-2026年予測)
...

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cell Therapy and Tissue Engineering Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Cell Therapy and Tissue Engineering market is valued at USD XX million in 2022 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2022 to 2026.

The report firstly introduced the Cell Therapy and Tissue Engineering basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
……

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Cell Therapy
Tissue Engineering
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cell Therapy and Tissue Engineering for each application, including-
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
……

❖ レポートの目次 ❖

Table of Contents

Part I Cell Therapy and Tissue Engineering Industry Overview

Chapter One Cell Therapy and Tissue Engineering Industry Overview
1.1 Cell Therapy and Tissue Engineering Definition
1.2 Cell Therapy and Tissue Engineering Classification Analysis
1.2.1 Cell Therapy and Tissue Engineering Main Classification Analysis
1.2.2 Cell Therapy and Tissue Engineering Main Classification Share Analysis
1.3 Cell Therapy and Tissue Engineering Application Analysis
1.3.1 Cell Therapy and Tissue Engineering Main Application Analysis
1.3.2 Cell Therapy and Tissue Engineering Main Application Share Analysis
1.4 Cell Therapy and Tissue Engineering Industry Chain Structure Analysis
1.5 Cell Therapy and Tissue Engineering Industry Development Overview
1.5.1 Cell Therapy and Tissue Engineering Product History Development Overview
1.5.1 Cell Therapy and Tissue Engineering Product Market Development Overview
1.6 Cell Therapy and Tissue Engineering Global Market Comparison Analysis
1.6.1 Cell Therapy and Tissue Engineering Global Import Market Analysis
1.6.2 Cell Therapy and Tissue Engineering Global Export Market Analysis
1.6.3 Cell Therapy and Tissue Engineering Global Main Region Market Analysis
1.6.4 Cell Therapy and Tissue Engineering Global Market Comparison Analysis
1.6.5 Cell Therapy and Tissue Engineering Global Market Development Trend Analysis

Chapter Two Cell Therapy and Tissue Engineering Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Cell Therapy and Tissue Engineering Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Cell Therapy and Tissue Engineering Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Cell Therapy and Tissue Engineering Market Analysis
3.1 Asia Cell Therapy and Tissue Engineering Product Development History
3.2 Asia Cell Therapy and Tissue Engineering Competitive Landscape Analysis
3.3 Asia Cell Therapy and Tissue Engineering Market Development Trend

Chapter Four 2017-2022 Asia Cell Therapy and Tissue Engineering Productions Supply Sales Demand Market Status and Forecast
4.1 2017-2022 Cell Therapy and Tissue Engineering Production Overview
4.2 2017-2022 Cell Therapy and Tissue Engineering Production Market Share Analysis
4.3 2017-2022 Cell Therapy and Tissue Engineering Demand Overview
4.4 2017-2022 Cell Therapy and Tissue Engineering Supply Demand and Shortage
4.5 2017-2022 Cell Therapy and Tissue Engineering Import Export Consumption
4.6 2017-2022 Cell Therapy and Tissue Engineering Cost Price Production Value Gross Margin

Chapter Five Asia Cell Therapy and Tissue Engineering Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information


Chapter Six Asia Cell Therapy and Tissue Engineering Industry Development Trend
6.1 2022-2026 Cell Therapy and Tissue Engineering Production Overview
6.2 2022-2026 Cell Therapy and Tissue Engineering Production Market Share Analysis
6.3 2022-2026 Cell Therapy and Tissue Engineering Demand Overview
6.4 2022-2026 Cell Therapy and Tissue Engineering Supply Demand and Shortage
6.5 2022-2026 Cell Therapy and Tissue Engineering Import Export Consumption
6.6 2022-2026 Cell Therapy and Tissue Engineering Cost Price Production Value Gross Margin

Part III North American Cell Therapy and Tissue Engineering Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Cell Therapy and Tissue Engineering Market Analysis
7.1 North American Cell Therapy and Tissue Engineering Product Development History
7.2 North American Cell Therapy and Tissue Engineering Competitive Landscape Analysis
7.3 North American Cell Therapy and Tissue Engineering Market Development Trend

Chapter Eight 2017-2022 North American Cell Therapy and Tissue Engineering Productions Supply Sales Demand Market Status and Forecast
8.1 2017-2022 Cell Therapy and Tissue Engineering Production Overview
8.2 2017-2022 Cell Therapy and Tissue Engineering Production Market Share Analysis
8.3 2017-2022 Cell Therapy and Tissue Engineering Demand Overview
8.4 2017-2022 Cell Therapy and Tissue Engineering Supply Demand and Shortage
8.5 2017-2022 Cell Therapy and Tissue Engineering Import Export Consumption
8.6 2017-2022 Cell Therapy and Tissue Engineering Cost Price Production Value Gross Margin

Chapter Nine North American Cell Therapy and Tissue Engineering Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information


Chapter Ten North American Cell Therapy and Tissue Engineering Industry Development Trend
10.1 2022-2026 Cell Therapy and Tissue Engineering Production Overview
10.2 2022-2026 Cell Therapy and Tissue Engineering Production Market Share Analysis
10.3 2022-2026 Cell Therapy and Tissue Engineering Demand Overview
10.4 2022-2026 Cell Therapy and Tissue Engineering Supply Demand and Shortage
10.5 2022-2026 Cell Therapy and Tissue Engineering Import Export Consumption
10.6 2022-2026 Cell Therapy and Tissue Engineering Cost Price Production Value Gross Margin

Part IV Europe Cell Therapy and Tissue Engineering Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Cell Therapy and Tissue Engineering Market Analysis
11.1 Europe Cell Therapy and Tissue Engineering Product Development History
11.2 Europe Cell Therapy and Tissue Engineering Competitive Landscape Analysis
11.3 Europe Cell Therapy and Tissue Engineering Market Development Trend

Chapter Twelve 2017-2022 Europe Cell Therapy and Tissue Engineering Productions Supply Sales Demand Market Status and Forecast
12.1 2017-2022 Cell Therapy and Tissue Engineering Production Overview
12.2 2017-2022 Cell Therapy and Tissue Engineering Production Market Share Analysis
12.3 2017-2022 Cell Therapy and Tissue Engineering Demand Overview
12.4 2017-2022 Cell Therapy and Tissue Engineering Supply Demand and Shortage
12.5 2017-2022 Cell Therapy and Tissue Engineering Import Export Consumption
12.6 2017-2022 Cell Therapy and Tissue Engineering Cost Price Production Value Gross Margin

Chapter Thirteen Europe Cell Therapy and Tissue Engineering Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information


Chapter Fourteen Europe Cell Therapy and Tissue Engineering Industry Development Trend
14.1 2022-2026 Cell Therapy and Tissue Engineering Production Overview
14.2 2022-2026 Cell Therapy and Tissue Engineering Production Market Share Analysis
14.3 2022-2026 Cell Therapy and Tissue Engineering Demand Overview
14.4 2022-2026 Cell Therapy and Tissue Engineering Supply Demand and Shortage
14.5 2022-2026 Cell Therapy and Tissue Engineering Import Export Consumption
14.6 2022-2026 Cell Therapy and Tissue Engineering Cost Price Production Value Gross Margin

Part V Cell Therapy and Tissue Engineering Marketing Channels and Investment Feasibility

Chapter Fifteen Cell Therapy and Tissue Engineering Marketing Channels Development Proposals Analysis
15.1 Cell Therapy and Tissue Engineering Marketing Channels Status
15.2 Cell Therapy and Tissue Engineering Marketing Channels Characteristic
15.3 Cell Therapy and Tissue Engineering Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Cell Therapy and Tissue Engineering New Project Investment Feasibility Analysis
17.1 Cell Therapy and Tissue Engineering Market Analysis
17.2 Cell Therapy and Tissue Engineering Project SWOT Analysis
17.3 Cell Therapy and Tissue Engineering New Project Investment Feasibility Analysis

Part VI Global Cell Therapy and Tissue Engineering Industry Conclusions

Chapter Eighteen 2017-2022 Global Cell Therapy and Tissue Engineering Productions Supply Sales Demand Market Status and Forecast
18.1 2017-2022 Cell Therapy and Tissue Engineering Production Overview
18.2 2017-2022 Cell Therapy and Tissue Engineering Production Market Share Analysis
18.3 2017-2022 Cell Therapy and Tissue Engineering Demand Overview
18.4 2017-2022 Cell Therapy and Tissue Engineering Supply Demand and Shortage
18.5 2017-2022 Cell Therapy and Tissue Engineering Import Export Consumption
18.6 2017-2022 Cell Therapy and Tissue Engineering Cost Price Production Value Gross Margin

Chapter Nineteen Global Cell Therapy and Tissue Engineering Industry Development Trend
19.1 2022-2026 Cell Therapy and Tissue Engineering Production Overview
19.2 2022-2026 Cell Therapy and Tissue Engineering Production Market Share Analysis
19.3 2022-2026 Cell Therapy and Tissue Engineering Demand Overview
19.4 2022-2026 Cell Therapy and Tissue Engineering Supply Demand and Shortage
19.5 2022-2026 Cell Therapy and Tissue Engineering Import Export Consumption
19.6 2022-2026 Cell Therapy and Tissue Engineering Cost Price Production Value Gross Margin

Chapter Twenty Global Cell Therapy and Tissue Engineering Industry Research Conclusions



★調査レポート[細胞療法&組織工学の世界市場 2022年-2026年] (コード:DMN22OT2091)販売に関する免責事項を必ずご確認ください。
★調査レポート[細胞療法&組織工学の世界市場 2022年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆